CNN @CNN
The FDA has declined to grant accelerated approval to an experimental Alzheimer’s drug, donanemab, and requested additional data from Eli Lilly and Company, the drug maker https://t.co/uBSL5Sk93X — PolitiTweet.org
Created
Fri Jan 20 23:45:07 +0000 2023
Likes
84
Retweets
28
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
CNN @CNN
The FDA has declined to grant accelerated approval to an experimental Alzheimer’s drug, donanemab, and requested additional data from Eli Lilly and Company, the drug maker https://t.co/uBSL5Sk93X — PolitiTweet.org